ARCHIVES

BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women

This article is from The Cancer Letter archive.

Vol. 04 No. 44 | November 3, 1978

Download PDF Visit The Full Archive

Related Articles

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

Broder On FDA: Don’t Blame Them For Doing Their Jobs (They Have To Work At Parklawn)

September 27, 1991

In Brief: NIH Conference To Explore Conflict Of Interest Issues; Five NCUI Executive Win PHS Awards

May 26, 1989

NCI Announces New Summer Training Awards

November 12, 1982

Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification

February 5, 1999

Obey Accuses Industry Of Blocking Control Of Carcinogens

November 10, 1978